Cargando…
Hesperetin conjugated PEGylated gold nanoparticles exploring the potential role in anti-inflammation and anti-proliferation during diethylnitrosamine-induced hepatocarcinogenesis in rats
Liver cancer is the fifth most common cancer and one of the leading causes of death in the world, and second most common cause of death in men. Natural products emerge as the most enduring approaches in the development of anticancer targeting drug. Hesperetin (HP), one of the abundant flavonoids fou...
Autores principales: | Krishnan, Gokuladhas, Subramaniyan, Jayakumar, Chengalvarayan Subramani, Pramila, Muralidharan, Barath, Thiruvengadam, Devaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shenyang Pharmaceutical University
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032104/ https://www.ncbi.nlm.nih.gov/pubmed/32104357 http://dx.doi.org/10.1016/j.ajps.2017.04.001 |
Ejemplares similares
-
Anticancer effect of caudatin in diethylnitrosamine-induced hepatocarcinogenesis in rats
por: Song, Jie, et al.
Publicado: (2020) -
Null anticarcinogenic effect of silymarin on diethylnitrosamine-induced hepatocarcinogenesis in rats
por: IMAMOTO, RYU, et al.
Publicado: (2014) -
Metformin inhibits early stage diethylnitrosamine-induced hepatocarcinogenesis in rats
por: JO, WOORI, et al.
Publicado: (2016) -
Tumor Promoting Effects of Sulforaphane on Diethylnitrosamine-Induced Murine Hepatocarcinogenesis
por: Zheng, Jie, et al.
Publicado: (2022) -
Preneoplastic and neoplastic progression during hepatocarcinogenesis in mice injected with diethylnitrosamine in infancy.
por: Goldfarb, S, et al.
Publicado: (1983)